Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

NovoCure Nears Profitability as Revenue Continues to Soar


NovoCure (NASDAQ: NVCR), a medical device company focused on oncology, reported its second-quarter results on Wednesday.

Revenue growth continues to remain strong and came in at 41% for the period. The sales leverage helped expand its gross margin, enabling the company to significantly reduce its bottom-line loses and produce operating income for the first time.

Metric

Continue reading


Quelle Fool.com

Like: 0
Share

Comments